LRCX · NASDAQ-GS
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $18.44B | $14.91B | $17.43B | $17.23B | $14.63B | $10.04B | $9.65B | $11.08B |
| Cost of Revenue | $9.46B | $7.85B | $9.65B | $9.36B | $7.82B | $5.44B | $5.30B | $5.91B |
| Gross Profit | $8.98B | $7.05B | $7.78B | $7.87B | $6.81B | $4.61B | $4.36B | $5.17B |
| Research & Development | $2.10B | $1.90B | $1.73B | $1.60B | $1.49B | $1.25B | $1.19B | $1.19B |
| Selling, General & Administrative | $981.70M | $868.25M | $832.75M | $885.74M | $829.88M | $682.48M | $702.41M | $762.22M |
| Operating Expenses | $3.08B | $2.79B | $2.60B | $2.49B | $2.32B | $1.93B | $1.89B | $1.95B |
| Operating Income | $5.90B | $4.26B | $5.17B | $5.38B | $4.48B | $2.67B | $2.46B | $3.21B |
| Interest Expense | $177.22M | $183.03M | $186.46M | $184.76M | $208.60M | $177.44M | $117.26M | $97.39M |
| Other Income / (Expense) | $57.16M | $96.31M | -$65.65M | -$188.71M | -$111.22M | -$98.82M | -$18.16M | -$61.51M |
| Income Before Taxes | $5.96B | $4.36B | $5.11B | $5.19B | $4.37B | $2.57B | $2.45B | $3.15B |
| Provision for Income Taxes | $599.91M | $532.45M | $598.28M | $587.83M | $462.35M | $323.23M | $255.14M | $771.11M |
| Net Income | $5.36B | $3.83B | $4.51B | $4.61B | $3.91B | $2.25B | $2.19B | $2.38B |
| Basic EPS | $4.17 | $2.91 | $3.33 | $32.92 | $27.22 | $15.55 | $14.37 | $14.73 |
| Diluted EPS | $4.15 | $2.90 | $3.32 | $32.75 | $26.90 | $15.10 | $13.70 | $13.17 |
| Basic Shares Outstanding | 1.29B | 1.31B | 1.35B | 139.90M | 143.61M | 144.81M | 152.48M | 161.64M |
| Diluted Shares Outstanding | 1.29B | 1.32B | 1.36B | 140.63M | 145.32M | 149.09M | 159.91M | 180.78M |
| Period | Consensus EPS | Low | High | Estimates | Revisions |
|---|---|---|---|---|---|
| Jun 2027 | $9.24 | $8.05 | $10.00 | 14 | ↑12 ↓0 |
| Jun 2028 | $11.34 | $9.74 | $12.39 | 8 | ↑5 ↓0 |
| Jun 2029 | $13.52 | $11.49 | $14.70 | 4 | ↑1 ↓0 |
| Jun 2030 | $15.45 | $14.10 | $16.80 | 2 | ↑1 ↓0 |